ULTOMIRIS Trademark

Trademark Overview

On Friday, December 8, 2017, a trademark application was filed for ULTOMIRIS with the United States Patent and Trademark Office. The USPTO has given the ULTOMIRIS trademark a serial number of 87713118. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, September 8, 2025. This trademark is owned by Alexion Pharmaceuticals, Inc.. The ULTOMIRIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological, autoimmune, immunological and inflammatory related diseases and disorders
ultomiris

General Information

Serial Number87713118
Word MarkULTOMIRIS
Filing DateFriday, December 8, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, September 8, 2025
Registration Number5716901
Registration DateTuesday, April 2, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 30, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hematological, autoimmune, immunological and inflammatory related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 19, 2017
Primary Code005
First Use Anywhere DateTuesday, January 8, 2019
First Use In Commerce DateTuesday, January 8, 2019

Trademark Owner History

Party NameAlexion Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameAlexion Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameAlexion Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Haven, CT 06510

Trademark Events

Event DateEvent Description
Tuesday, December 12, 2017NEW APPLICATION ENTERED
Tuesday, December 19, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 21, 2018ASSIGNED TO EXAMINER
Wednesday, March 21, 2018NON-FINAL ACTION WRITTEN
Wednesday, March 21, 2018NON-FINAL ACTION E-MAILED
Wednesday, March 21, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 13, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 19, 2018ASSIGNED TO LIE
Wednesday, September 26, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 26, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 27, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 10, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 30, 2018PUBLISHED FOR OPPOSITION
Tuesday, October 30, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, November 9, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, November 9, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 25, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 9, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, January 9, 2019USE AMENDMENT FILED
Monday, February 4, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 4, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, February 25, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 26, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 2, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, April 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 2, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, April 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 16, 2025TEAS SECTION 8 & 15 RECEIVED
Tuesday, March 18, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 18, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 18, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 18, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 5, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 7, 2025POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Wednesday, August 13, 2025TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Monday, September 8, 2025POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
Monday, September 8, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, September 8, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

ultomiris inflammatory related diseases disorders immunological autoimmune preparations treatment hematological pharmaceutical